Otivio

Otivio AS is a privately owned company based in Oslo, Norway. The company was founded in 2010 based on IP, prototypes and clinical data developed at University of Oslo. Otivio is ISO 13485 certified. The core technology enables increased blood flow to the limbs of a patient. Otivio’s main product, FlowOx™, is addressing peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Early long-term patient testing documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked.

Our Team

Andreas Mollatt

CEO

am@otivio.com

+47 934 46 261

Klaus Skjærsgaard

CCO

ks@otivio.com

Please reload

Iacob Mathiesen

CSO

im@otivio.com

+47 468 90 416

Brian Alberts

Project and Logistic Coordinator

ba@otivio.com

+4793005210

Henrik Hoel

Clinical Researcher

hh@otivio.com

Please reload

Hans Petter Tjeldflaat

CFO

hpt@otivio.com

Ira Sankhayan

Head of QA and Reg. Assurance

ira@otivio.com

Jody McIntosh

Clinical Researcher

jm@otivio.com

Please reload

© 2023 by Gracious Dwelling. Proudly created with Wix.com

  • Facebook - Grey Circle

|  +47 934 46 261   |   info@otivio.com